Institutional development · Research, innovation and assessment · Argentina
Argentine team reports step towards a vaccine to reinforce BCG tuberculosis immunity
The news service of the University of Buenos Aires science faculty says an Argentine research team has advanced towards a vaccine that would reinforce or complement the immunity left by BCG.
Why it matters: The University of Buenos Aires science faculty reports that an Argentine team has moved closer to a vaccine reinforcing or complementing BCG immunity.
The news service of the Faculty of Exact and Natural Sciences at the University of Buenos Aires reported that an Argentine research team has taken a significant step towards a vaccine that would reinforce or complement BCG-induced immunity.
According to the faculty's report, BCG protects against severe tuberculosis in early childhood, but its effectiveness falls sharply in adults.
The report states that one in four people worldwide is infected with the tuberculosis bacterium.
Editor’s view
Scott James, Research and Innovation Editor
The faculty reports that the Argentine team has taken a significant step towards a vaccine designed to reinforce or complement the immunity BCG leaves, a jab whose effectiveness, according to the same report, falls markedly in adults.